- Home
- VGI vs MDXH Comparison
VGI vs MDXH Comparison
Compare VGI & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGI
- MDXH
- Stock Information
- Founded
- VGI 2012
- MDXH 2003
- Country
- VGI United States
- MDXH Belgium
- Employees
- VGI N/A
- MDXH N/A
- Industry
- VGI Investment Managers
- MDXH
- Sector
- VGI Finance
- MDXH
- Exchange
- VGI Nasdaq
- MDXH Nasdaq
- Market Cap
- VGI N/A
- MDXH 84.6M
- IPO Year
- VGI N/A
- MDXH 2021
- Fundamental
- Price
- VGI $7.80
- MDXH $2.18
- Analyst Decision
- VGI
- MDXH Buy
- Analyst Count
- VGI 0
- MDXH 1
- Target Price
- VGI N/A
- MDXH $6.00
- AVG Volume (30 Days)
- VGI 46.0K
- MDXH 64.4K
- Earning Date
- VGI 01-01-0001
- MDXH 08-20-2025
- Dividend Yield
- VGI 12.66%
- MDXH N/A
- EPS Growth
- VGI N/A
- MDXH N/A
- EPS
- VGI N/A
- MDXH N/A
- Revenue
- VGI N/A
- MDXH $94,507,000.00
- Revenue This Year
- VGI N/A
- MDXH $23.51
- Revenue Next Year
- VGI N/A
- MDXH $17.68
- P/E Ratio
- VGI N/A
- MDXH N/A
- Revenue Growth
- VGI N/A
- MDXH 25.46
- 52 Week Low
- VGI $6.68
- MDXH $1.35
- 52 Week High
- VGI $7.99
- MDXH $3.50
- Technical
- Relative Strength Index (RSI)
- VGI 51.48
- MDXH 53.89
- Support Level
- VGI $7.82
- MDXH $2.17
- Resistance Level
- VGI $7.87
- MDXH $2.22
- Average True Range (ATR)
- VGI 0.06
- MDXH 0.08
- MACD
- VGI -0.01
- MDXH -0.01
- Stochastic Oscillator
- VGI 34.62
- MDXH 44.22
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.